共 87 条
- [1] Cibula D(2018)The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of patients with cervical cancer Virchows Arch 472 919-936
- [2] Pötter R(2019)Cervical cancer Lancet 393 169-182
- [3] Planchamp F(2016)Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: where do we stand? A literature review Crit Rev Oncol Hematol 108 164-174
- [4] Cohen PA(1997)Identification of high-risk groups among node-positive patients with stage IB and IIA cervical carcinoma Gynecol Oncol 64 463-467
- [5] Jhingran A(1989)Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix Gynecol Oncol 33 34-39
- [6] Oaknin A(1990)Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study Gynecol Oncol 38 352-357
- [7] Boussios S(2000)Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 1606-1613
- [8] Seraj E(2006)A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study Int J Radiat Oncol Biol Phys 65 169-176
- [9] Zarkavelis G(2016)Margins for cervical and vulvar cancer J Surg Oncol 113 304-309
- [10] Samlal RA(2016)Clinical implications of positive margins following non-small cell lung cancer surgery J Surg Oncol 113 264-269